期刊文献+

术前BNP及Copeptin浓度和老年非心脏手术心血管事件的关系 被引量:1

The Relationship between Preoperative BNP and Copeptin Concentration and Cardiovascular Events in Elderly Patients with Non Cardiac Surgery
下载PDF
导出
摘要 目的:探讨术前B型钠尿肽(BNP)及和肽素(copeptin)浓度的变化与老年非心脏手术心血管事件的关系。方法:选取我院于2012年8月至2013年1月期间入院患者,依据术后患者是否发生心血管事件将患者分为两组,分析两组患者术前与术后BNP及copeptin浓度的变化情况。结果:BNP浓度大于100ng/m L对心脏事件具有诱发作用,发生心脏事件的患者血浆BNP浓度要显著高于未发生心脏事件的患者。血浆中copeptin浓度越高,诱发患者发生心脏事件的可能性越大,结果具有统计学意义。结论:术前BNP及copeptin浓度较正常值偏高的老年患者易发生非心脏手术心血管事件,对该类患者进行手术时应考虑相应风险性因素。 Objective: To investigate the relationship between the changes of type B natriuretic peptide( BNP) and peptide( copeptin) concentration and cardiovascular events in elderly patients with non cardiac surgery. Methods: From August 2012 to January 2013,patients with the occurrence of cardiovascular events were divided into two groups,and analyzed the changes of BNP and copeptin concentration patients of the two groups before and after surgery. Results: BNP concentration more than 100 ng/m L for cardiac events had a role in the occurrence of cardiac events in patients with plasma BNP,which concentrations were significantly higher than those who did not occur in patients with cardiac events. The higher the concentration of copeptin in plasma,the greater the possibility of the occurrence of cardiac events in patients,the results were statistically significant. Conclusion: Preoperative BNP and copeptin concentrations are higher than the normal value of the elderly patients with non cardiac surgery,cardiovascular events,the patients should be considered the corresponding risk factors.
出处 《河北医学》 CAS 2017年第3期371-374,共4页 Hebei Medicine
基金 上海市黄浦区科委区卫生局科研项目 (编号:2012-HGG-1)
关键词 BNP水平 copeptin浓度 非心脏手术心血管事件 BNP level Copeptin concentration Cardiovascular events in non cardiac surgery
  • 相关文献

参考文献5

二级参考文献29

  • 1刘颖珍,洪韵琳,张大为,张瑾,王德昌,齐军.胸部肿瘤术后心律失常原因探讨[J].中华胸心血管外科杂志,1995,11(2):81-83. 被引量:151
  • 2Martin GJ,Magid NM,Myers G,et al.Heart rate variability and sudden death secondary to coronary artery diseas during ambulatory electrocardiographic monitoring[J].Am J Cardiol,1997;41:1247-7.
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 4Morawice B,Kawecki D.Copeptin:a new marker in cardiology[J].J Cardiovasc Med(Haders-town),2013;14:19-25.
  • 5Morgenthaler NG,Struck J,Alonso C,et al.Assay for the measurement of copeptin a stable peptide derived from the precursor of vasopressin[J].Clin Chemm,2006;52(1):112-9.
  • 6Lemmens-Gruber R,Kamyar M.Vasopressin antagonists[J].Cell Mol Life Sci,2006;63(15):1766-79.
  • 7Khan SQ,Dhillon OS,O'Brien RJ,et al.C-terminal provasopressin(copeptin)as a novel and prognostic marker in acute myocardial infarction:leicester acute myocardial infarction peptide(LAMP)Study[J].Circulation,2007;115(16):2103-10.
  • 8Struck J,Morgenthaler NG,Bergmann A.Copeptin,a stable peptide derived from the vasopressin precursor,is elevated in serum of sepsis patients peptides[J].Clin Chen,2005;26:2500-24.
  • 9Maisel A,Mueiier C,Neath S,et al.Copeptin helps in the early detection of patients with acute myocardial infarction[J].J Am Coll Cardiol,2013;62:150-60.
  • 10Meune C,Zuily S,Wahbi K,et al.Combination of copeptin and high sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction:a pilot study[J].Arch Cardiovasc Dis,2011;104:4-10.

共引文献18

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部